- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
[作者:Wen, PY; Macdonald, DR; Reardon, DA; Cloughesy, TF; Sorensen, AG; Galanis, E; DeGroot, J; Wick, W; Gilbert, MR; Lassman, AB; Tsien, C; Mikkelsen, T; Wong, ET; Chamberlain, MC; Stupp, R; Lamborn, KR; Vogelbaum, MA; van den Bent, MJ; Chang, SM,期刊:Journal of clinical oncology, 页码:1963-1972 , 文章类型: Article,,卷期:2010年28-11]
- Currently, the most widely used criteria for assessing response to therapy in high-grade gliomas are based on two-dimensional tumor measurements on computed tomography (CO or magnetic resonance imaging (MRI), in conjunct...
- Comparative In Vitro Cellular Data Alone Are Insufficient to Predict Clinical Responses and Guide the Choice of BCR-ABL Inhibitor for Treating Imatinib-Resistant Chronic Myeloid Leukemia
[作者:Laneuville, P; DiLea, C; Yin, OQP; Woodman, RC; Mestan, J; Manley, PW,期刊:Journal of clinical oncology, 页码:E169-E171 , 文章类型: Letter,,卷期:2010年28-11]
-
- Predictors of Benefit in Colorectal Cancer Treated With Cetuximab: Are We Getting "Lost in TranslationAL"?
[作者:Cremolini, C; Loupakis, F; Ruzzo, A; Perrone, G; Rulli, E; Vincenzi, B; Tonini, G; Graziano, F; Muda, AO; Falcone, A,期刊:Journal of clinical oncology, 页码:E173-E174 , 文章类型: Letter,,卷期:2010年28-11]
-
- Predictors of Benefit in Colorectal Cancer Treated With Cetuximab: Are We Getting "Lost in TranslationAL"? Reply
[作者:Jacobs, B; De Roock, W; Piessevaux, H; Biesmans, B; De Schutter, J; Claes, B; Tejpar, S,期刊:Journal of clinical oncology, 页码:E175-E176 , 文章类型: Letter,,卷期:2010年28-11]
-
- Identification of Subtypes in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Reveals a Gene Signature Prognostic of Outcome
[作者:Staaf, J; Ringner, M; Vallon-Christersson, J; Jonsson, G; Bendahl, PO; Holm, K; Arason, A; Gunnarsson, H; Hegardt, C; Agnarsson, BA; Luts, L; Grabau, D; Ferno, M; Malmstrom, PO; Johannsson, OT; Loman, N; Barkardottir, RB; Borg, A,期刊:Journal of clinical oncology, 页码:1813-1820 , 文章类型: Article,,卷期:2010年28-11]
- Purpose Human epidermal growth factor receptor 2 (HER2) gene amplification or protein overexpression (HER2 positivity) defines a clinically challenging subgroup of patients with breast cancer (BC) with variable prognosis...
- Predictors of Tumor Progression During Neoadjuvant Chemotherapy in Breast Cancer
[作者:Caudle, AS; Gonzalez-Angulo, AM; Hunt, KK; Liu, P; Pusztai, L; Symmans, WF; Kuerer, HM; Mittendorf, EA; Hortobagyi, GN; Meric-Bernstam, F,期刊:Journal of clinical oncology, 页码:1821-1828 , 文章类型: Article,,卷期:2010年28-11]
- Purpose Although most breast cancer patients who receive neoadjuvant chemotherapy (NCT) have a tumor response, a small proportion experience progressive disease (PD). Predictors of response have been reported, but predic...
- Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study
[作者:Dowsett, M; Cuzick, J; Wale, C; Forbes, J; Mallon, EA; Salter, J; Quinn, E; Dunbier, A; Baum, M; Buzdar, A; Howell, A; Bugarini, R; Baehner, FL; Shak, S,期刊:Journal of clinical oncology, 页码:1829-1834 , 文章类型: Article,,卷期:2010年28-11]
- Purpose To determine whether the Recurrence Score (RS) provided independent information on risk of distant recurrence (DR) in the tamoxifen and anastrozole arms of the Arimidex, Tamoxifen, Alone or in Combination (ATAC) ...
- Phase III Study of Carboplatin and Paclitaxel Alone or With Sorafenib in Advanced Non Small-Cell Lung Cancer
[作者:Scagliotti, G; Novello, S; von Pawel, J; Reck, M; Pereira, JR; Thomas, M; Miziara, JEA; Balint, B; De Marinis, F; Keller, A; Aren, O; Csollak, M; Albert, I; Barrios, CH; Grossi, F; Krzakowski, M; Cupit, L; Cihon, F; DiMatteo, S; Hanna, N,期刊:Journal of clinical oncology, 页码:1835-1842 , 文章类型: Article,,卷期:2010年28-11]
- Purpose This phase If, multicenter, randomized, placebo controlled trial assessed the efficacy and safety of sorafenib, an oral multikinase inhibitor, in combination with carboplatin and paclitaxel in chemotherapy naive ...
- Surgery With or Without Preoperative Paclitaxel and Carboplatin in Early-Stage Non-Small-Cell Lung Cancer: Southwest Oncology Group Trial S9900, an Intergroup, Randomized, Phase III Trial
[作者:Pisters, KMW; Vallieres, E; Crowley, JJ; Franklin, WA; Bunn, PA; Ginsberg, RJ; Putnam, JB; Chansky, K; Gandara, D,期刊:Journal of clinical oncology, 页码:1843-1849 , 文章类型: Article,,卷期:2010年28-11]
- Purpose Patients with early stage non-small-cell lung cancer (NSCLC) have a poor prognosis even after complete resection. Earlier studies of preoperative (induction) chemotherapy in resectable NSCLC demonstrated feasibil...
|